Eltek VP lists employee stock option holdings
ELTEK LTD executive Segev Raviv, VP of Process & Technology, reported his initial holdings of employee stock options on a Form 3.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
ELTEK LTD executive Segev Raviv, VP of Process & Technology, reported his initial holdings of employee stock options on a Form 3. He holds options over 7,000 ordinary shares at an exercise price of $8.82 per share and options over 15,000 ordinary shares at $8.84 per share.
According to the option agreements, each grant vests over four years: 25% becomes exercisable on the first anniversary of the grant date, with an additional 6.25% becoming exercisable at the end of each subsequent quarter. The options expire in 2036 on their respective expiration dates.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Segev Raviv
Role
VP of Process & Technology
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee Stock Option | -- | -- | -- |
| holding | Employee Stock Option | -- | -- | -- |
Holdings After Transaction:
Employee Stock Option — 22,000 contracts (Direct)
Footnotes (2)
- F1. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on January 1, 2026
- F2. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on March 8, 2026
Key Figures
Option grant 1 underlying shares: 7,000 shares
Option grant 1 exercise price: $8.82/share
Option grant 1 expiration: 2036-03-08
+5 more
8 metrics
Option grant 1 underlying shares
7,000 shares
Underlying ordinary shares for first employee stock option
Option grant 1 exercise price
$8.82/share
Exercise price for first employee stock option
Option grant 1 expiration
2036-03-08
Expiration date for first employee stock option
Option grant 2 underlying shares
15,000 shares
Underlying ordinary shares for second employee stock option
Option grant 2 exercise price
$8.84/share
Exercise price for second employee stock option
Option grant 2 expiration
2036-01-01
Expiration date for second employee stock option
Initial vesting portion
25%
Options exercisable on first anniversary of grant date
Quarterly vesting portion
6.25%
Additional options exercisable at end of each subsequent quarter
Key Terms
Employee Stock Option, Ordinary share, exercise price, grant date, +1 more
5 terms
Employee Stock Option financial
"security_title: "Employee Stock Option""
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
exercise price financial
"exercisePrice: "8.8200" and "8.8400""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
grant date financial
"The option was granted on January 1, 2026"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
exercisable over a four-year period financial
"The option agreement provides that the option will become exercisable over a four-year period."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Eltek (ELTK) VP Segev Raviv report on this Form 3?
VP of Process & Technology Segev Raviv reports his initial holdings of employee stock options. These options give him the right to acquire Eltek ordinary shares at fixed exercise prices, with vesting spread over four years under the terms described in the option agreements.
What are the exercise prices of Segev Raviv’s Eltek (ELTK) employee stock options?
One option grant has an exercise price of $8.82 per ordinary share, and the other has an exercise price of $8.84 per ordinary share. These fixed prices determine what Raviv would pay per share if he chooses to exercise the options in the future.
How do Segev Raviv’s Eltek stock options vest over time?
Each option grant vests over four years. Twenty-five percent of the options become exercisable on the first anniversary of the grant date, and an additional 6.25% become exercisable at the end of each subsequent quarter, gradually increasing the portion he can exercise.
When do Segev Raviv’s Eltek (ELTK) employee stock options expire?
The options have long-dated expirations in 2036. One grant expires on March 8, 2036, and the other expires on January 1, 2036. After the respective expiration dates, any unexercised options from each grant can no longer be exercised.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates